Literature DB >> 2169936

Antagonism of swim-stress-induced antinociception by the delta-opioid receptor antagonist naltrindole in adult and young rats.

I Kitchen1, S R Pinker.   

Abstract

1. The availability of the non-peptide delta-opioid receptor antagonist naltrindole has provided the possibility for in vivo studies on the function of delta-opioid receptors. We have studied the effects of naltrindole on swim-stress-induced antinociception in adult and neonatal rats. 2. Adult, 25 and 20 day old rats were stressed by warm water (20 degrees C) swimming for 3 min periods and antinociception was assessed by the tail immersion test (50 degrees C). 3. Naltrindole (0.5 and 1 mg kg-1) antagonized swim-stress-induced antinociception in adult and 25 day old rats but in 20 day old rats naltrindole (1 mg kg-1) was without effect. 4. Antinociception induced by the highly mu-opioid receptor selective agonist alfentanil was completely antagonized by naloxone (1 mg kg-1) but virtually unaffected by naltrindole (1 mg kg-1). 5. Neither naloxone nor naltrindole (1 mg kg-1) antagonized swim-stress-induced rises in plasma corticosterone in adult rats at the time of peak antinociception. 6. In conclusion, naltrindole shows in vivo antagonism of opioid-mediated responses. Swim-stress-induced antinociception is mediated through the delta-opioid receptor in 25 day old and adult rats and through the mu-opioid site in 20 day old animals.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2169936      PMCID: PMC1917588          DOI: 10.1111/j.1476-5381.1990.tb14076.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  Differences in the effects of mu- and delta-opioid receptor antagonists upon plasma corticosterone levels in stressed mice.

Authors:  I Kitchen; K M Rowan
Journal:  Eur J Pharmacol       Date:  1984-05-18       Impact factor: 4.432

2.  Selective antagonists at the opiate delta-receptor.

Authors:  J S Shaw; L Miller; M J Turnbull; J J Gormley; J S Morley
Journal:  Life Sci       Date:  1982 Sep 20-27       Impact factor: 5.037

3.  ICI 174864: a highly selective antagonist for the opioid delta-receptor.

Authors:  R Cotton; M G Giles; L Miller; J S Shaw; D Timms
Journal:  Eur J Pharmacol       Date:  1984-01-27       Impact factor: 4.432

Review 4.  Classification of opioid receptors.

Authors:  S J Paterson; L E Robson; H W Kosterlitz
Journal:  Br Med Bull       Date:  1983-01       Impact factor: 4.291

5.  Low-level lead exposure alters morphine antinociception in neonatal rats.

Authors:  I Kitchen; J McDowell; C Winder; J M Wilson
Journal:  Toxicol Lett       Date:  1984-08       Impact factor: 4.372

6.  Opioid and nonopioid mechanisms of stress analgesia.

Authors:  J W Lewis; J T Cannon; J C Liebeskind
Journal:  Science       Date:  1980-05-09       Impact factor: 47.728

7.  Alfentanil: a study of its analgesic activity and interactions with morphine in the mouse.

Authors:  J G Williams; J H Brown; B J Pleuvry
Journal:  Br J Anaesth       Date:  1982-01       Impact factor: 9.166

8.  Site-directed alkylation of multiple opioid receptors. I. Binding selectivity.

Authors:  I F James; A Goldstein
Journal:  Mol Pharmacol       Date:  1984-05       Impact factor: 4.436

9.  Endogenous opioid peptides: multiple agonists and receptors.

Authors:  J A Lord; A A Waterfield; J Hughes; H W Kosterlitz
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

10.  The effects of selective opioid delta-receptor antagonists on stress-induced antinociception and plasma corticosterone levels in mice.

Authors:  S L Hart; H Slusarczyk; T W Smith
Journal:  Neuropeptides       Date:  1985-02       Impact factor: 3.286

View more
  12 in total

1.  Preweanling naltrindole administration differentially affects clonidine induced antinociception and plasma adrenaline levels in male and female neonatal rats.

Authors:  I Alberti; B Fernández; L F Alguacil; A Aguilar; M Caamaño; E M Romero; M P Viveros
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

Review 2.  A review on animal models for screening potential anti-stress agents.

Authors:  Amteshwar Singh Jaggi; Nitish Bhatia; Naresh Kumar; Nirmal Singh; Preet Anand; Ravi Dhawan
Journal:  Neurol Sci       Date:  2011-09-17       Impact factor: 3.307

3.  Electrophysiological studies on the postnatal development of the spinal antinociceptive effects of the delta opioid receptor agonist DPDPE in the rat.

Authors:  W Rahman; A H Dickenson
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

4.  Delta-opiod receptor-mediated forced swimming stress-induced antinociception in the formalin test.

Authors:  J Kamei; H Hitosugi; M Misawa; H Nagase; Y Kasuya
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Activation of the opioid μ1, but not δ or κ, receptors is required for nicotine reinforcement in a rat model of drug self-administration.

Authors:  Xiu Liu; Courtney Jernigan
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-10-20       Impact factor: 5.067

6.  Role of kappa and delta opioid receptors in mediating morphine-induced antinociception in morphine-tolerant infant rats.

Authors:  Dawn C Stoller; Laura J Sim-Selley; Forrest L Smith
Journal:  Brain Res       Date:  2007-01-13       Impact factor: 3.252

7.  Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats.

Authors:  T J Crook; I Kitchen; R G Hill
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

8.  Effect of delayed weaning on opioid receptor control of swim stress-induced antinociception in the developing rat.

Authors:  B Y Muhammad; I Kitchen
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

9.  Lack of involvement of delta-opioid receptors in mediating the rewarding effects of cocaine.

Authors:  T J de Vries; D Babovic-Vuksanovic; G Elmer; T S Shippenberg
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

10.  Pharmacological evaluation of the gabapentin salicylaldehyde derivative, gabapentsal, against tonic and phasic pain models, inflammation, and pyrexia.

Authors:  Nisar Ahmad; Fazal Subhan; Nazar Ul Islam; Muhammad Shahid; Naseem Ullah; Rahim Ullah; Muhammad Khurram; Muhammad Usman Amin; Shehla Akbar; Ihsan Ullah; Robert D E Sewell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-07-12       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.